Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP versus adipose-derived mesenchymal stem cells for knee osteoarthritis
PACTR202503493655424Phase 0Recruiting
- Sponsor
- Mohammed VI University Hospital
- Start
- Mar 2025
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 0, open-label trial of adipose derived mesenchymal stromal cells and platelet-rich plasma in knee osteoarthritis (OA) (2 arms), sponsored by Mohammed VI University Hospital. Primary endpoint: Comparative efficacy of adipose-derived MSCs versus PRP in knee osteoarthritis. Started Mar 2025; status: recruiting.
02
Drugs
adipose derived mesenchymal stromal cellsplatelet-rich plasma
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on PACTR202503493655424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202503493655424.